Utah Medical Products UTMD Foreign currency translation gains (losses)
Foreign currency translation gains (losses) at other companies
Other financials
Where this comes from
Reported directly by Utah Medical Products in its filing.
Tagged under the XBRL concept us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax.
The official record: Utah Medical Products’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Utah Medical Products's foreign currency translation gains (losses).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Utah Medical Products's foreign currency translation gains (losses)?
- Utah Medical Products (UTMD) reported foreign currency translation gains (losses) of -$503K in Q1 2026.
- How has Utah Medical Products's foreign currency translation gains (losses) changed year-over-year?
- Utah Medical Products's foreign currency translation gains (losses) decreased by 170.1% year-over-year, from $718K to -$503K.
- What is the long-term trend for Utah Medical Products's foreign currency translation gains (losses)?
- Over 3 years (2021 to 2025), Utah Medical Products's foreign currency translation gains (losses) has grown at a 46.8% compound annual growth rate (CAGR), from -$787K to $2.49M.
- What does foreign currency translation gains (losses) mean?
- This metric measures the gains or losses arising from the translation of financial statements denominated in foreign currencies into the company's functional reporting currency. It highlights the sensitivity of the company's international business footprint to macroeconomic currency shifts.